Pottier Nicolas, Chupin Cécile, Defamie Virginie, Cardinaud Bruno, Sutherland Rachel, Rios Géraldine, Gauthier Francis, Wolters Paul J, Berthiaume Yves, Barbry Pascal, Mari Bernard
IPMC, CNRS UMR6097, 660, route des Lucioles, F06560 Sophia Antipolis, France.
Am J Respir Crit Care Med. 2007 Dec 1;176(11):1098-107. doi: 10.1164/rccm.200607-1051OC. Epub 2007 Aug 2.
Different sensitivities to profibrotic compounds such as bleomycin are observed among mouse strains.
To identify genetic factors contributing to the outcome of lung injury.
Physiological comparison of C57BL/6 (sensitive) and BALB/c (resistant) mice challenged by intratracheal bleomycin instillation revealed several early differences: global gene expression profiles were thus established from lungs derived from the two strains, in the absence of any bleomycin administration.
Expression of 25 genes differed between the two strains. Among them, two molecules, not previously associated with pulmonary fibrosis, were identified. The first corresponded to dipeptidyl-peptidase I (DPPI), a cysteine peptidase (also known as cathepsin C) essential for the activation of serine proteinases produced by immune/inflammatory cells. The second corresponded to tissue inhibitor of matrix metalloproteinase-3, which also inhibits members of the ADAM (a disintegrin and metalloproteinase) family, such as the tumor necrosis factor-converting enzyme. In functional studies performed in the bleomycin-induced lung fibrosis model, the level of expression of these two genes was closely correlated with specific early events associated with lung fibrosis, namely activation of polymorphonuclear neutrophil-derived serine proteases and tumor necrosis factor-alpha-dependent inflammatory syndrome. Surprisingly, genetic deletion of DPPI in the context of a C57BL/6 genetic background did not protect against bleomycin-mediated fibrosis, suggesting additional function(s) for this key enzyme.
This study highlights the importance of the early inflammatory events that follow bleomycin instillation in the development of lung fibrosis, and describes for the first time the roles that DPPI and tissue inhibitor of matrix metalloproteinase-3 may play in this process.
在小鼠品系中观察到对诸如博来霉素等促纤维化化合物的不同敏感性。
确定导致肺损伤结果的遗传因素。
对经气管内注入博来霉素攻击的C57BL/6(敏感)和BALB/c(抗性)小鼠进行生理学比较,发现了几个早期差异:因此,在未给予任何博来霉素的情况下,从这两个品系的肺中建立了全局基因表达谱。
两个品系之间有25个基因的表达存在差异。其中,鉴定出两个以前未与肺纤维化相关的分子。第一个对应于二肽基肽酶I(DPPI),一种半胱氨酸肽酶(也称为组织蛋白酶C),对免疫/炎症细胞产生的丝氨酸蛋白酶的激活至关重要。第二个对应于基质金属蛋白酶-3的组织抑制剂,它也抑制ADAM(一种解整合素和金属蛋白酶)家族的成员,如肿瘤坏死因子转化酶。在博来霉素诱导的肺纤维化模型中进行的功能研究中,这两个基因的表达水平与与肺纤维化相关的特定早期事件密切相关,即多形核中性粒细胞衍生的丝氨酸蛋白酶的激活和肿瘤坏死因子-α依赖性炎症综合征。令人惊讶的是,在C57BL/6遗传背景下对DPPI进行基因缺失并不能预防博来霉素介导的纤维化,这表明这种关键酶还有其他功能。
本研究强调了博来霉素注入后早期炎症事件在肺纤维化发展中的重要性,并首次描述了DPPI和基质金属蛋白酶-3组织抑制剂在这一过程中可能发挥的作用。